The Medical Advisor

An evidence‑aware guide to off‑label cancer therapies, integrative oncology, precision oncology and emerging research — without hype or false promises. This page serves as the central hub for OneDayMD’s coverage of repurposed drugs and precision oncology in cancer care, integrating conventional oncology standards with systems biology, real‑world data, and ethical analysi s. What This Hub Covers (Quick Overview) This hub explains: What repurposed drugs are — and what they are not. Which drugs show credible anti‑cancer signals vs speculation. How repurposed therapies may (or may not) integrate with standard oncology. The evidence hierarchy used across OneDayMD. Safety, ethics, and regulatory realities. It is designed for patients, clinicians, and researchers seeking clarity rather than promotion . Diverse cancer hallmarks targeted by repurposed non-oncology drugs. This figure was created with Biorender.com. Source:  Nature 2024 Executive Summary Repurposed drugs in cancer care ref...

Cancer treatment is no longer one-dimensional. For decades, chemotherapy dominated oncology.  Today, treatment may include chemotherapy, targeted therapy, immunotherapy — or carefully designed combinations of all three. Yet confusion persists. Patients often ask: Is chemotherapy outdated? Is immunotherapy safer? Is targeted therapy more effective? Why do some people respond dramatically while others do not? This guide explains the science, clinical evidence, benefits, risks, and real-world decision-making framework behind modern oncology — grounded in standards used by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. What is immunotherapy? Cancer cells are abnormal cells that replicate uncontrollably. Normally, your immune system destroys abnormal cells, but many types of cancer ce...

Ivermectin Resources I have seen tremendous demand for some sort of initial guidance “WHERE TO START” with High Dose Ivermectin for CANCER. Editor's Note: Dr Makis proposes four distinct cancer protocols for using Ivermectin in cancer treatment, specifically for patients who have developed turbo cancer or aggressive cancers. These protocols, referred to as the “Dr. Makis Ivermectin Cancer Protocols,” are categorized based on dosage and the severity of the cancer. Updated version I have an article and a video that go into depth: June 10, 2024 - "15 minutes with Dr.Makis" - Episode 018: High Dose Ivermectin and Cancer .  2025 - 2026 studies on ivermectin for cancer Clinical Yuan Yuan et al (Cedars-Sinai Medical Center) - A phase I/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer (ASCO 2025) Hulscher et al -  Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer ...